You can now read 5 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

Ariad adds activist investor to board

Activist investor Alexander J. Denner has been named to a two-year term on the board of Cambridge biotech Ariad Pharmaceuticals Inc., the company said Friday.

Denner, a protege of Carl C. Icahn and veteran of many battles with biotechnology managers, recently founded his own hedge fund, Sarissa Capital Management of Greenwich, Conn. The fund bought a 6.2 percent stake in Ariad last October, according to a regulatory filing, and Denner has been agitating for a seat on Ariad’s board.

Continue reading below

The company, which lost more than half its stock value last year amid safety concerns over its blood cancer drug Iclusig, has been a rumored takeover candidate. Denner’s appointment boosts the number of Ariad directors to nine. Ariad said it plans to add a 10th.

Neither Denner nor an Ariad representative immediately responded to requests for comment.

Robert Weisman can be reached at Follow him on Twitter @GlobeRobW.
Loading comments...
Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
Please enter a valid email will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of